VALERIO, LAURA Statistiche
VALERIO, LAURA
DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE
5 Years Follow Up Of Thyroglobulin (Tg), Thyroglobulin Antibodies (Tgab) And Neck Ultrasound (Nus) In Patients With Papillary Thyroid Microcarcinoma (Mptc) Treated With Total Thyroidectomy But Not Ablated With 131I
2016-01-01 Matrone, Antonio; Faranda, Alessio; Molinaro, Eleonora; Agate, Laura; Viola, David; Valerio, Laura; Giani, Carlotta; Liborio, Torregrossa; Piaggi, Paolo; Vitti, Paolo; Elisei, Rossella
5 YEARS FOLLOW UP OF THYROGLOBULIN (TG), THYROGLOBULIN ANTIBODIES (TGAB) AND NECK ULTRASOUND (US) IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA (MPTC) TREATED WITH TOTAL THYROIDECTOMY BUT NOT ABLATED WITH 131I
2015-01-01 Matrone, A.; Faranda, A.; Molinaro, E.; Agate, L.; Viola, D.; Valerio, L.; Giani, C.; Torregrossa, L.; Piaggi, P.; Vitti, P.; Elisei, R.
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion.
2019-01-01 Giani, Carlotta; Romei, Cristina; Ciampi, Raffaele; Valerio, Laura; Tacito, Alessia; Ramone, Teresa; Materazzi, Gabriele; Torregrossa, Liborio; Ugolini, Clara; Franchi, Alessandro; Basolo, Fulvio; Agate, Laura; Elisei, Rossella
A rare adverse event (AE) in a group of radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) patients in therapy with lenvatinib.
2019-01-01 Puleo, Luciana; Giani, Carlotta; Valerio, Laura; Viola, David; Molinaro, Eleonora; Elisei, Rossella; Agate, Laura
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center
2020-01-01 Molinaro, Eleonora; Campopiano, Maria Cristina; Pieruzzi, Letizia; Matrone, Antonio; Agate, Laura; Bottici, Valeria; Viola, David; Cappagli, Virginia; Valerio, Laura; Giani, Carlotta; Puleo, Luciana; Lorusso, Loredana; Piaggi, Paolo; Torregrossa, Liborio; Basolo, Fulvio; Vitti, Paolo; Tuttle, R Michael; Elisei, Rossella
Active surveillance in ret gene carriers belonging to families with multiple endocrine neoplasia
2021-01-01 Prete, A.; Matrone, A.; Gambale, C.; Bottici, V.; Cappagli, V.; Romei, C.; Torregrossa, L.; Valerio, L.; Minaldi, E.; Campopiano, M. C.; Lorusso, L.; Agate, L.; Molinaro, E.; Viola, D.; Ramone, T.; Mule, C.; Ciampi, R.; Basolo, F.; Elisei, R.
Clinical pharmacology and drug-drug interactions of lenvatinib in thyroid cancer
2021-01-01 Fogli, S.; Gianfilippo, G.; Cucchiara, F.; Del Re, M.; Valerio, L.; Elisei, R.; Danesi, R.
Correction to: Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer (Journal of Endocrinological Investigation, (2021), 44, 10, (2139-2151), 10.1007/s40618-020-01491-3)
2021-01-01 Matrone, A.; Prete, A.; Nervo, A.; Ragni, A.; Agate, L.; Molinaro, E.; Giani, C.; Valerio, L.; Minaldi, E.; Piovesan, A.; Elisei, R.
DELAYED 131-I FIRST TREATMENT AFTER SURGERY HAS NO IMPACT ON THE MEDIAN TERM OUTCOME OF PATIENTS WITH INTERMEDIATE RISK DIFFERENTIATED THYROID CANCER
2020-01-01 Matrone, Antonio; Gambale, Carla; Torregrossa, Liborio; Piaggi, Paolo; Bianchi, Francesca; Valerio, Laura; Viola, David; Agate, Laura; Molinaro, Eleonora; Materazzi, Gabriele; Basolo, Fulvio; Vitti, Paolo; Elisei, Rossella
Delayed radioiodine remnant ablation (RRA) does not impact on the outcome of intermediate risk for recurrence differentiated thyroid cancer patients (IR-DTC).
2018-01-01 Matrone, Antonio; Gambale, Carla; Torregrossa, Liborio; Bianchi, Francesca; Valerio, Laura; Viola, David; Agate, Laura; Molinaro, Eleonora; Basolo, Fulvio; Vitti, Paolo; Elisei, Rossella
Delayed radioiodine remnant ablation (RRA) does not impact on the outcome of intermediate risk for recurrence differentiated thyroid cancer patients (IR-DTC).
2018-01-01 Matrone, A.; Gambale, C.; Torregrossa, L.; Bianchi, F.; Valerio, L.; Viola, D.; Agate, L.; Molinaro, E.; Basolo, F.; Vitti, P.; Elisei, R.
Expression of duox1 in papillary thyroid cancer and in normal thyroid tissues and correlation with ret/ptc rearrangements
2018-01-01 Valerio, L.; Torregrossa, L.; Niccoli, C.; Matrone, A.; Basolo, F.; Elisei, Rossella
FDG-PET/CT Correlates with the Response of Radiorefractory Thyroid Cancer to Lenvatinib and Patient Survival
2021-01-01 Valerio, L.; Guidoccio, F.; Giani, C.; Tardelli, E.; Puccini, G.; Puleo, L.; Minaldi, E.; Boni, G.; Elisei, R.; Volterrani, D.
Fenotipo misto MEN2A/MEN2B da nuova mutazione germinale di RET: prima descrizione clinico-genetica e iconografia
2020-01-01 Giani, Carlotta; Ramone, Teresa; Romei, Cristina; Ciampi, Raffaele; Valerio, Laura; Tacito, Alessia; Agate, Laura; Ugolini, Clara; Marinò, Michele; Basolo, Fulvio; Franchi, Alessandro; Borsari, Simona; Michelucci, Angela; Selli, Cesare; Materazzi, Gabriele; Cetani, Filomena; Elisei, Rossella
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases
2019-01-01 Elisei, R; Matrone, A; Valerio, L; Molinaro, E; Agate, L; Bottici, V; Viola, D; Giani, C; Cappagli, V; Latrofa, F; Materazzi, G; Torregrossa, L; Ugolini, C; Basolo, F; Romei, C.
Hypertension, nausea, anorexia and weight loss were significantly associated with better progression-free survival in patients with radioiodine-Refractory Differentiated Thyroid Carcinoma treated with Lenvatinib
2018-01-01 Giani, C.; Valerio, L.; Pieruzzi, L.; Agate, L.; Viola, D.; Bottici, V.; Piaggi, P.; Lorusso, L.; Cappagli, V.; Puleo, L.; Matrone, A.; Mazzeo, S.; Ribechini, A.; Vitti, P.; Molinaro, E.; Elisei, Rossella
Il carcinoma tiroideo: nuove prospettive terapeutiche.
2014-01-01 Viola, David; Agate, Laura; Molinaro, Eleonora; Bottici, Valeria; Lorusso, Loredana; Valerio, Laura; Matrone, Antonio; Biagini, Agnese; Cappagli, Virginia; Giani, Carlotta; Pieruzzi, Letizia; Contillo, Benedetta Pontillo; Battaglia, Valentina; Mazzeo, Salvatore; Elisei, Rossella
Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer
2016-01-01 Lorusso, Loredana; Pieruzzi, Letizia; Biagini, Agnese; Sabini, Elena; Valerio, Laura; Giani, Carlotta; Passannanti, PAOLO FRANCESCO; PONTILLO CONTILLO, Benedetta; Battaglia, Valentina; Mazzeo, Salvatore; Molinaro, Eleonora; Elisei, Rossella
Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer
2021-01-01 Matrone, A; Prete, A; Nervo, A; Ragni, A; Agate, L; Molinaro, E; Giani, C; Valerio, L; Minaldi, E; Piovesan, A; Elisei, R
Lenvatinib therapy in progressive, radioiodine-refractory, differentiated thyroid carcinoma: analysis of 74 cases followed in a single centre
2018-01-01 Giani, C; Valerio, L; Pieruzzi, L; Agate, L; Viola, D; Bottici, V; Piaggi, P; Lorusso, L; Cappagli, V; Puleo, L; Matrone, A; Mazzeo, S; Pontillo-Contillo, B; Ribechini, A; Vitti, P; Molinaro, E; Elisei, R.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 5 Years Follow Up Of Thyroglobulin (Tg), Thyroglobulin Antibodies (Tgab) And Neck Ultrasound (Nus) In Patients With Papillary Thyroid Microcarcinoma (Mptc) Treated With Total Thyroidectomy But Not Ablated With 131I | 1-gen-2016 | Matrone, Antonio; Faranda, Alessio; Molinaro, Eleonora; Agate, Laura; Viola, David; Valerio, Laura; Giani, Carlotta; Liborio, Torregrossa; Piaggi, Paolo; Vitti, Paolo; Elisei, Rossella | |
| 5 YEARS FOLLOW UP OF THYROGLOBULIN (TG), THYROGLOBULIN ANTIBODIES (TGAB) AND NECK ULTRASOUND (US) IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA (MPTC) TREATED WITH TOTAL THYROIDECTOMY BUT NOT ABLATED WITH 131I | 1-gen-2015 | Matrone, A.; Faranda, A.; Molinaro, E.; Agate, L.; Viola, D.; Valerio, L.; Giani, C.; Torregrossa, L.; Piaggi, P.; Vitti, P.; Elisei, R. | |
| A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. | 1-gen-2019 | Giani, Carlotta; Romei, Cristina; Ciampi, Raffaele; Valerio, Laura; Tacito, Alessia; Ramone, Teresa; Materazzi, Gabriele; Torregrossa, Liborio; Ugolini, Clara; Franchi, Alessandro; Basolo, Fulvio; Agate, Laura; Elisei, Rossella | |
| A rare adverse event (AE) in a group of radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) patients in therapy with lenvatinib. | 1-gen-2019 | Puleo, Luciana; Giani, Carlotta; Valerio, Laura; Viola, David; Molinaro, Eleonora; Elisei, Rossella; Agate, Laura | |
| Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center | 1-gen-2020 | Molinaro, Eleonora; Campopiano, Maria Cristina; Pieruzzi, Letizia; Matrone, Antonio; Agate, Laura; Bottici, Valeria; Viola, David; Cappagli, Virginia; Valerio, Laura; Giani, Carlotta; Puleo, Luciana; Lorusso, Loredana; Piaggi, Paolo; Torregrossa, Liborio; Basolo, Fulvio; Vitti, Paolo; Tuttle, R Michael; Elisei, Rossella | |
| Active surveillance in ret gene carriers belonging to families with multiple endocrine neoplasia | 1-gen-2021 | Prete, A.; Matrone, A.; Gambale, C.; Bottici, V.; Cappagli, V.; Romei, C.; Torregrossa, L.; Valerio, L.; Minaldi, E.; Campopiano, M. C.; Lorusso, L.; Agate, L.; Molinaro, E.; Viola, D.; Ramone, T.; Mule, C.; Ciampi, R.; Basolo, F.; Elisei, R. | |
| Clinical pharmacology and drug-drug interactions of lenvatinib in thyroid cancer | 1-gen-2021 | Fogli, S.; Gianfilippo, G.; Cucchiara, F.; Del Re, M.; Valerio, L.; Elisei, R.; Danesi, R. | |
| Correction to: Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer (Journal of Endocrinological Investigation, (2021), 44, 10, (2139-2151), 10.1007/s40618-020-01491-3) | 1-gen-2021 | Matrone, A.; Prete, A.; Nervo, A.; Ragni, A.; Agate, L.; Molinaro, E.; Giani, C.; Valerio, L.; Minaldi, E.; Piovesan, A.; Elisei, R. | |
| DELAYED 131-I FIRST TREATMENT AFTER SURGERY HAS NO IMPACT ON THE MEDIAN TERM OUTCOME OF PATIENTS WITH INTERMEDIATE RISK DIFFERENTIATED THYROID CANCER | 1-gen-2020 | Matrone, Antonio; Gambale, Carla; Torregrossa, Liborio; Piaggi, Paolo; Bianchi, Francesca; Valerio, Laura; Viola, David; Agate, Laura; Molinaro, Eleonora; Materazzi, Gabriele; Basolo, Fulvio; Vitti, Paolo; Elisei, Rossella | |
| Delayed radioiodine remnant ablation (RRA) does not impact on the outcome of intermediate risk for recurrence differentiated thyroid cancer patients (IR-DTC). | 1-gen-2018 | Matrone, Antonio; Gambale, Carla; Torregrossa, Liborio; Bianchi, Francesca; Valerio, Laura; Viola, David; Agate, Laura; Molinaro, Eleonora; Basolo, Fulvio; Vitti, Paolo; Elisei, Rossella | |
| Delayed radioiodine remnant ablation (RRA) does not impact on the outcome of intermediate risk for recurrence differentiated thyroid cancer patients (IR-DTC). | 1-gen-2018 | Matrone, A.; Gambale, C.; Torregrossa, L.; Bianchi, F.; Valerio, L.; Viola, D.; Agate, L.; Molinaro, E.; Basolo, F.; Vitti, P.; Elisei, R. | |
| Expression of duox1 in papillary thyroid cancer and in normal thyroid tissues and correlation with ret/ptc rearrangements | 1-gen-2018 | Valerio, L.; Torregrossa, L.; Niccoli, C.; Matrone, A.; Basolo, F.; Elisei, Rossella | |
| FDG-PET/CT Correlates with the Response of Radiorefractory Thyroid Cancer to Lenvatinib and Patient Survival | 1-gen-2021 | Valerio, L.; Guidoccio, F.; Giani, C.; Tardelli, E.; Puccini, G.; Puleo, L.; Minaldi, E.; Boni, G.; Elisei, R.; Volterrani, D. | |
| Fenotipo misto MEN2A/MEN2B da nuova mutazione germinale di RET: prima descrizione clinico-genetica e iconografia | 1-gen-2020 | Giani, Carlotta; Ramone, Teresa; Romei, Cristina; Ciampi, Raffaele; Valerio, Laura; Tacito, Alessia; Agate, Laura; Ugolini, Clara; Marinò, Michele; Basolo, Fulvio; Franchi, Alessandro; Borsari, Simona; Michelucci, Angela; Selli, Cesare; Materazzi, Gabriele; Cetani, Filomena; Elisei, Rossella | |
| Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases | 1-gen-2019 | Elisei, R; Matrone, A; Valerio, L; Molinaro, E; Agate, L; Bottici, V; Viola, D; Giani, C; Cappagli, V; Latrofa, F; Materazzi, G; Torregrossa, L; Ugolini, C; Basolo, F; Romei, C. | |
| Hypertension, nausea, anorexia and weight loss were significantly associated with better progression-free survival in patients with radioiodine-Refractory Differentiated Thyroid Carcinoma treated with Lenvatinib | 1-gen-2018 | Giani, C.; Valerio, L.; Pieruzzi, L.; Agate, L.; Viola, D.; Bottici, V.; Piaggi, P.; Lorusso, L.; Cappagli, V.; Puleo, L.; Matrone, A.; Mazzeo, S.; Ribechini, A.; Vitti, P.; Molinaro, E.; Elisei, Rossella | |
| Il carcinoma tiroideo: nuove prospettive terapeutiche. | 1-gen-2014 | Viola, David; Agate, Laura; Molinaro, Eleonora; Bottici, Valeria; Lorusso, Loredana; Valerio, Laura; Matrone, Antonio; Biagini, Agnese; Cappagli, Virginia; Giani, Carlotta; Pieruzzi, Letizia; Contillo, Benedetta Pontillo; Battaglia, Valentina; Mazzeo, Salvatore; Elisei, Rossella | |
| Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer | 1-gen-2016 | Lorusso, Loredana; Pieruzzi, Letizia; Biagini, Agnese; Sabini, Elena; Valerio, Laura; Giani, Carlotta; Passannanti, PAOLO FRANCESCO; PONTILLO CONTILLO, Benedetta; Battaglia, Valentina; Mazzeo, Salvatore; Molinaro, Eleonora; Elisei, Rossella | |
| Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer | 1-gen-2021 | Matrone, A; Prete, A; Nervo, A; Ragni, A; Agate, L; Molinaro, E; Giani, C; Valerio, L; Minaldi, E; Piovesan, A; Elisei, R | |
| Lenvatinib therapy in progressive, radioiodine-refractory, differentiated thyroid carcinoma: analysis of 74 cases followed in a single centre | 1-gen-2018 | Giani, C; Valerio, L; Pieruzzi, L; Agate, L; Viola, D; Bottici, V; Piaggi, P; Lorusso, L; Cappagli, V; Puleo, L; Matrone, A; Mazzeo, S; Pontillo-Contillo, B; Ribechini, A; Vitti, P; Molinaro, E; Elisei, R. |